Figure GPS-18. Overview of drug prevalence estimates from various studies in Europe for all adults (aged 15 to 64) and young adults (aged 15 to 34) [see all figures in this series...]

Part (ii) Cocaine, amphetamines and ecstasy use — lifetime experience, last 12 months and last 30 days prevalence

Notes:

For each country, the average of the sample prevalences, weighted by sample size, is indicated by the highlighted data point.

Links:

Statistical bulletin 2006: Figure GPS-33 part (ii)

Statistical bulletin 2007: Figure GPS-18 part (ii)

Statistical bulletin 2008: Figure GPS-18 part (ii)

Statistical bulletin 2009: Figure GPS-18 part (ii)

See also Table GPS-0

For details of the studies included see Tables GPS-7 to GPS-9

See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

Reitox national reports 2009, taken from population surveys, reports or scientific articles.